Lifestyle modifications, including yoga, hypnosis, and nutraceuticals, are increasingly used in BPH management, reflecting a trend towards integrating alternative medicine with traditional treatments.

Intravesical chemotherapy counseling differs for women due to potential skin irritation and leakage issues, necessitating specific skin care advice. Topical hormone therapy, such as vaginal estrogen ...

The NRG-GU011 trial investigates relugolix plus SBRT versus SBRT alone in PET-oligometastatic prostate cancer. ORIOLE and STOMP studies indicate SBRT can delay recurrence without early ADT in some ...

The study is a large, multi-center, independently funded cohort series on Peyronie's disease treatment satisfaction. Patients who underpredict their penile curvature report higher satisfaction ...

What is the current evidence base supporting PRP use for Peyronie disease, and in what patient populations might it be considered a viable option? PRP has really increased in popularity because it's ...

The revised policy will take effect on January 1, 2025. The Centers for Medicare & Medicaid Services (CMS) has announced an adjustment under the CY 2025 Hospital Outpatient Prospective Payment System ...

In total, the study plans to enroll 84 adult patients across clinical trial sites in the United States and Australia. The first patient has been enrolled and treated in the PPRT trial (NCT06496256), ...

Gallium PSMA-11 gozetotide is effective in detecting prostate cancer metastases and assessing biochemical recurrence with high sensitivity and specificity. The tracer is particularly useful for ...

mCSPC and mHSPC refer to prostate cancer with metastases that remain responsive to hormone therapy, often used interchangeably. Both conditions involve the presence of metastases and sensitivity to ...

"We were actually interested in looking at what was the impact of prostate cancer on sexual quality of life for female partners of patients," says Stacy Loeb, MD, MSc, PhD (hon). In this video, Stacy ...

Olaparib significantly improved radiographic progression-free survival and overall survival in metastatic prostate cancer with HRR gene alterations. Safety profiles of PARP inhibitors were consistent ...

The TALAPRO-2 study authors noted that the use of androgen receptor (AR)–targeted therapy in clinical practice has increased considerably in recent years. How might prior use of AR-targeted therapy ...